Streetbeat News

Products Services

WVE

Wave Life Sciences Ltd. announced its participation in the 2024 MDA Clinical & Scientific Conference, highlighting the potential of WVE-N531 for Duchenne muscular dystrophy (DMD). The presentations will showcase clinical and preclinical data, including the first evidence of satellite cell uptake in DMD therapy, significant drug concentrations in non-human primates, and the impact of Wave's PN chemistry on exon skipping and dystrophin restoration. The FORWARD-53 study is evaluating WVE-N531's ability to restore dystrophin, with 24-week data expected in Q3 2024.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 1:44 pm

OTLY

Oatly Group AB (NASDAQ:OTLY), the leading oatmilk company, has expanded its North American beverage portfolio with the launch of Oatly Oatmilk Creamers in the US. These new creamers come in four flavors and are designed for coffee. With plant-based creamers seeing significant sales growth, Oatly aims to capture both new and existing customers. The creamers will be available nationwide at major retailers. This launch builds on Oatly's existing range of non-dairy milk alternatives and aligns with the company's mission to offer sustainable, allergen-free, and vegan options.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 1:43 pm

RBA

Ritchie Bros. Auctioneers (NYSE:RBA) reported a successful premier global auction event in Orlando, FL, from Feb. 19-23, generating over $258 million in gross transaction value from the sale of 16,500+ equipment items, trucks, and vehicles. The event attracted 22,000+ bidders from over 80 countries, with 83% of equipment sold to U.S. buyers. Additionally, Ritchie Bros.' online platforms hosted auctions in Australia and on IronPlanet, contributing to a total of over $300 million in GTV sold last week.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 1:42 pm

HEPS

Hepsiburada (NASDAQ:HEPS), a leading Turkish e-commerce platform, announced the appointment of Hakan Karadoğan as Chief Executive Officer of Logistics, effective March 25, 2024. Karadoğan, with extensive experience in logistics and supply chain management, including a tenure at Amazon and General Electric, is expected to drive Hepsiburada's logistics operations to new heights. The company also announced the departure of Chief Logistics Officer Mehmethan Yallagöz, effective March 31, 2024.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 1:40 pm

SIDU

Sidus Space has successfully encapsulated its LizzieSat satellite, with a launch now scheduled. This marks a significant milestone for the company as it progresses towards its space mission objectives.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 1:38 pm

LIXT

LIXTE Biotechnology announced the presentation of pre-clinical data on its product LB-100 at a joint conference of European and American Associations for Cancer Research in Dublin, Ireland, scheduled for February 27-29, 2024. The conference will focus on translating basic science discoveries into clinical applications.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 1:36 pm

ZM

Zoom Video Communications Inc (NASDAQ:ZM) reported better-than-expected Q4 financial results, issued strong guidance, and announced a new $1.5 billion share repurchase program. Q4 revenue rose 2.6% YoY to $1.15 billion, surpassing estimates. Earnings per share were $1.42, beating estimates of $1.15. The company ended the quarter with 220,400 enterprise customers, a 3.5% increase YoY, and introduced Zoom AI Companion. FY24 revenue is expected to be around $4.6 billion, with earnings between $4.85 and $4.88 per share.

Portfolio Pulse from Adam Eckert

February 27, 2024 | 1:35 pm

ADEA

PARA

Adeia has renewed its multi-year intellectual property (IP) license agreement with Paramount, ensuring continued collaboration between the two companies. This renewal signifies the ongoing value of Adeia's IP portfolio to Paramount's operations and could influence investor sentiment towards both companies.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 1:34 pm

SYNX

Silynxcom has received a repeat order worth $280,000 from a military customer, indicating continued trust and satisfaction with their products. This order could signal strong ongoing relationships and potential for future orders, positively impacting Silynxcom's financial performance.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 1:34 pm

CAPR

Capricor Therapeutics has announced a Type-B meeting with the FDA to discuss commercial manufacturing planning for CAP-1002, aimed at expediting the Biologics License Application (BLA) pathway for treating Duchenne Muscular Dystrophy.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 1:32 pm